1. Home
  2. ISTR vs LCTX Comparison

ISTR vs LCTX Comparison

Compare ISTR & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$28.54

Market Cap

394.5M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.31

Market Cap

388.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
LCTX
Founded
2006
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.5M
388.6M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
ISTR
LCTX
Price
$28.54
$1.31
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$31.50
$6.25
AVG Volume (30 Days)
126.1K
1.4M
Earning Date
04-20-2026
05-14-2026
Dividend Yield
1.59%
N/A
EPS Growth
4.41
N/A
EPS
0.77
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$66.56
$109.40
Revenue Next Year
$5.18
N/A
P/E Ratio
$37.13
N/A
Revenue Growth
N/A
53.24
52 Week Low
$17.89
$0.64
52 Week High
$30.49
$2.09

Technical Indicators

Market Signals
Indicator
ISTR
LCTX
Relative Strength Index (RSI) 56.01 40.54
Support Level $26.18 $1.14
Resistance Level $28.84 $1.31
Average True Range (ATR) 0.50 0.08
MACD 0.06 -0.00
Stochastic Oscillator 72.19 31.67

Price Performance

Historical Comparison
ISTR
LCTX

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: